| Product Code: ETC7537226 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The autoimmune and inflammatory immunomodulators import shipments to India continued to see significant growth in 2024, with the top exporting countries being the USA, Metropolitan France, India, Switzerland, and Canada. The market concentration, as measured by the Herfindahl-Hirschman Index (HHI), remained very high in 2024, indicating a competitive market dominated by a few key players. The compound annual growth rate (CAGR) from 2020 to 2024 was impressive at 23.04%, although there was a slight decline in growth rate from 2023 to 2024 at -1.51%. This data suggests a strong and stable market for autoimmune and inflammatory immunomodulators in India.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Autoimmune and Inflammatory Immunomodulators Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Autoimmune and Inflammatory Immunomodulators Market Revenues & Volume, 2021 & 2031F |
3.3 India Autoimmune and Inflammatory Immunomodulators Market - Industry Life Cycle |
3.4 India Autoimmune and Inflammatory Immunomodulators Market - Porter's Five Forces |
3.5 India Autoimmune and Inflammatory Immunomodulators Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 India Autoimmune and Inflammatory Immunomodulators Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 India Autoimmune and Inflammatory Immunomodulators Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of autoimmune diseases in India |
4.2.2 Growing awareness about immunomodulatory therapies |
4.2.3 Technological advancements in the development of immunomodulators |
4.3 Market Restraints |
4.3.1 High cost associated with autoimmune and inflammatory immunomodulators |
4.3.2 Stringent regulatory requirements for drug approval in India |
4.3.3 Limited access to advanced treatment options in rural areas |
5 India Autoimmune and Inflammatory Immunomodulators Market Trends |
6 India Autoimmune and Inflammatory Immunomodulators Market, By Types |
6.1 India Autoimmune and Inflammatory Immunomodulators Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India Autoimmune and Inflammatory Immunomodulators Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 India Autoimmune and Inflammatory Immunomodulators Market Revenues & Volume, By Biologics, 2021- 2031F |
6.1.4 India Autoimmune and Inflammatory Immunomodulators Market Revenues & Volume, By Small Molecules, 2021- 2031F |
6.2 India Autoimmune and Inflammatory Immunomodulators Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 India Autoimmune and Inflammatory Immunomodulators Market Revenues & Volume, By Oncology, 2021- 2031F |
6.2.3 India Autoimmune and Inflammatory Immunomodulators Market Revenues & Volume, By Respiratory, 2021- 2031F |
6.2.4 India Autoimmune and Inflammatory Immunomodulators Market Revenues & Volume, By HIV, 2021- 2031F |
6.2.5 India Autoimmune and Inflammatory Immunomodulators Market Revenues & Volume, By Rheumatoid Arthritis, 2021- 2031F |
6.2.6 India Autoimmune and Inflammatory Immunomodulators Market Revenues & Volume, By Others, 2021- 2031F |
7 India Autoimmune and Inflammatory Immunomodulators Market Import-Export Trade Statistics |
7.1 India Autoimmune and Inflammatory Immunomodulators Market Export to Major Countries |
7.2 India Autoimmune and Inflammatory Immunomodulators Market Imports from Major Countries |
8 India Autoimmune and Inflammatory Immunomodulators Market Key Performance Indicators |
8.1 Patient adherence rate to immunomodulatory therapies |
8.2 Number of clinical trials conducted for new immunomodulators in India |
8.3 Rate of adoption of biologic therapies in autoimmune and inflammatory diseases |
9 India Autoimmune and Inflammatory Immunomodulators Market - Opportunity Assessment |
9.1 India Autoimmune and Inflammatory Immunomodulators Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 India Autoimmune and Inflammatory Immunomodulators Market Opportunity Assessment, By Application, 2021 & 2031F |
10 India Autoimmune and Inflammatory Immunomodulators Market - Competitive Landscape |
10.1 India Autoimmune and Inflammatory Immunomodulators Market Revenue Share, By Companies, 2024 |
10.2 India Autoimmune and Inflammatory Immunomodulators Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here